Comparison of Immune Response Following Surgical Management of Renal Tumors

This study is currently recruiting participants.

Verified by Emory University, February 2006

First Received: February 7, 2006 No Changes Posted

Sponsored by:	Emory University
Information provided by:	Emory University
ClinicalTrials.gov Identifier:	NCT00289146

Purpose

Examine the effects of renal surgery on the immune system.

Condition
Kidney Cancer

MedlinePlus related topics: Cancer Kidney Cancer Surgery

U.S. FDA Resources

Study Type:	Observational
Study Design:	Natural History, Longitudinal, Defined Population, Prospective Study
Official Title:	Comparison of Immune Response Following Surgical Management of Renal Tumors

Further study details as provided by Emory University:

Estimated Enrollment:	50
Study Start Date:	November 2005
Estimated Study Completion Date:	November 2005

Detailed Description:

Prospective study examining the effects of different surgical procedures on immune function. This may have bearing on overall cancer specific recurrence and survival.

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria: - kidney tumor Exclusion Criteria: -

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00289146

Contacts

Contact: Kenneth Ogan, MD

404-778-3038

kenneth_ogan@emoryhealthcare.org

Locations

United States, Georgia
Emory University	Not yet recruiting
Atlanta, Georgia, United States, 30322
Contact: Kenneth Ogan, MD
Emory University	Recruiting
Atlanta, Georgia, United States, 30322
Contact: Beverly Lopez, RN 404-778-4162 beverly.lopez@emoryhealthcare.org

Sponsors and Collaborators

Emory University

Investigators

Principal Investigator:

Kenneth Ogan, MD

Emory University

More Information

No publications provided

Study ID Numbers:	IRB3 021-2005
Study First Received:	February 7, 2006
Last Updated:	February 7, 2006
ClinicalTrials.gov Identifier:	NCT00289146 History of Changes
Health Authority:	United States: Food and Drug Administration

Keywords provided by Emory University:

kidney cancer, immunology

Study placed in the following topic categories:

Urinary Tract Neoplasm
Kidney Cancer
Renal Cancer
Urologic Diseases
Kidney Neoplasms
Carcinoma, Renal Cell

Urogenital Neoplasms
Kidney Diseases
Urologic Neoplasms
Adenocarcinoma
Neoplasms, Glandular and Epithelial
Carcinoma

Additional relevant MeSH terms:

Neoplasms
Neoplasms by Site
Neoplasms by Histologic Type
Urologic Diseases
Kidney Neoplasms
Carcinoma, Renal Cell

Urogenital Neoplasms
Kidney Diseases
Urologic Neoplasms
Adenocarcinoma
Neoplasms, Glandular and Epithelial
Carcinoma

ClinicalTrials.gov processed this record on May 07, 2009